{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T15:21:51Z","timestamp":1790349711681,"version":"4.1.0"},"reference-count":0,"publisher":"Managed Care and Healthcare Communications, LLC","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Manag Care"],"DOI":"10.37765\/ajmc.2021.88726","type":"journal-article","created":{"date-parts":[[2021,8,27]],"date-time":"2021-08-27T19:07:21Z","timestamp":1630091241000},"page":"e254-e260","source":"Crossref","is-referenced-by-count":20,"title":["Cost-effectiveness of nivolumab in patients with NSCLC in the United States"],"prefix":"10.37765","volume":"27","member":"24492","published-online":{"date-parts":[[2021,8,24]]},"container-title":["The American Journal of Managed Care"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,8,27]],"date-time":"2021-08-27T19:07:22Z","timestamp":1630091242000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ajmc.com\/view\/cost-effectiveness-of-nivolumab-in-patients-with-nsclc-in-the-united-states"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,24]]},"references-count":0,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,8,1]]},"published-print":{"date-parts":[[2021,8,1]]}},"URL":"https:\/\/doi.org\/10.37765\/ajmc.2021.88726","archive":["Portico"],"relation":{},"ISSN":["1936-2692","1088-0224"],"issn-type":[{"value":"1936-2692","type":"electronic"},{"value":"1088-0224","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8,24]]}}}